<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55865</article-id><article-id pub-id-type="doi">10.7554/eLife.55865</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-174601"><name><surname>Pavlović</surname><given-names>Nataša</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174602"><name><surname>Calitz</surname><given-names>Carlemi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174603"><name><surname>Thanapirom</surname><given-names>Kess</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174604"><name><surname>Mazza</surname><given-names>Guiseppe</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174605"><name><surname>Rombouts</surname><given-names>Krista</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174606"><name><surname>Gerwins</surname><given-names>Pär</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-155603"><name><surname>Heindryckx</surname><given-names>Femke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1987-7676</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Medical Cell Biology</institution>, <institution>Uppsala University</institution>, <addr-line><named-content content-type="city">Uppsala</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">Medical Cell Biology</institution>, <institution>Uppsala University</institution>, <addr-line><named-content content-type="city">Uppsala</named-content></addr-line>, <country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-109554"><name><surname>Postovit</surname><given-names>Lynne-Marie</given-names></name><role>Reviewing editor</role><aff><institution>University of Alberta</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>femke.heindryckx@mcb.uu.se</email> (FH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e55865</elocation-id><history><date date-type="received"><day>09</day><month>02</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Pavlović et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Pavlović et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55865-v1.pdf"/><abstract><p>Hepatocellular carcinoma (HCC) is a liver tumor that usually arises in patients with cirrhosis. Hepatic stellate cells are key players in the progression of HCC, as they create a fibrotic micro-environment and produce growth factors and cytokines that enhance tumor cell proliferation and migration. We assessed the role of endoplasmic reticulum (ER) stress in the cross-talk between stellate cells and HCC-cells. Mice with a fibrotic HCC were treated with the IRE1α-inhibitor 4μ8C, which reduced tumor burden and collagen deposition. By co-culturing HCC-cells with stellate cells, we found that HCC-cells activate IREα in stellate cells, thereby contributing to their activation. Inhibiting IRE1α blocked stellate cell activation, which then decreased proliferation and migration of tumor cells in different <italic>in vitro</italic> 2D and 3D co-cultures. In addition, we also observed cell-line specific direct effects of inhibiting IRE1α in tumor cells.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>CAN 2017/518</award-id><principal-award-recipient><name><surname>Heindryckx</surname><given-names>Femke</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003748</institution-id><institution>Svenska Sällskapet för Medicinsk Forskning</institution></institution-wrap></funding-source><award-id>S17-0092</award-id><principal-award-recipient><name><surname>Heindryckx</surname><given-names>Femke</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>OE och Edla Johanssons stiftelse</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Heindryckx</surname><given-names>Femke</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Olga Jonssons stiftelse</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Heindryckx</surname><given-names>Femke</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations by FELASA. All of the animals were handled according to approved institutional animal care and Uppsala University approved protocols were used. The protocol was approved by the Committee on the Ethics of Animal Experiments of Uppsala  (C95/14). All effort was made to minimise suffering and to decrease animal usage.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Proteomics data has been deposited in Dryad with the following DOI: https://doi.org/10.5061/dryad.6wwpzgmv2</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Heindryckx F</collab></person-group><year iso-8601-date="2020">2020</year><source>Protein expression of hepatocellular carcinoma in a fibrotic liver in mice.</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.6wwpzgmv2">http://dx.doi.org/10.5061/dryad.6wwpzgmv2</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.6wwpzgmv2</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Seok JY</collab><collab>Na DC</collab><collab>Woo HG</collab><collab>Roncalli M</collab><collab>Kwon SM</collab><collab>Yoo JE</collab><collab>Ahn EY</collab><collab>Kim GI</collab><collab>Choi J</collab><collab>Kim YB</collab><collab>Park YN</collab></person-group><year iso-8601-date="2020">2020</year><source>Fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31370">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31370</ext-link><comment>NCBI Gene Expression Omnibus, GSE31370</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Uhlén M</collab><collab>Fagerberg L</collab><collab>Hallström BM</collab><collab>Lindskog C</collab><collab>Oksvold P</collab><collab>Mardinoglu A</collab><collab>Sivertsson Å</collab><collab>Kampf C</collab><collab>Sjöstedt E</collab><collab>Asplund A</collab><collab>Olsson I</collab><collab>Edlund K</collab><collab>Lundberg E</collab><collab>Navani S</collab><collab>Szigyarto CA</collab><collab>Odeberg J</collab><collab>Djureinovic D</collab><collab>Takanen JO</collab><collab>Hober S</collab><collab>Alm T</collab><collab>Edqvist PH</collab><collab>Berling H</collab><collab>Tegel H</collab><collab>Mulder J</collab><collab>Rockberg J</collab><collab>Nilsson P</collab><collab>Schwenk JM</collab><collab>Hamsten M</collab><collab>von Feilitzen K</collab><collab>Forsberg M</collab><collab>Persson L</collab><collab>Johansson F</collab><collab>Zwahlen M</collab><collab>von Heijne G</collab><collab>Nielsen J</collab><collab>Pontén F</collab></person-group><year iso-8601-date="2015">2015</year><source>Proteomics. Tissue-based map of the human proteome.</source><ext-link ext-link-type="uri" xlink:href="https://www.proteinatlas.org">https://www.proteinatlas.org</ext-link><comment>Human protein atlas</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-55865-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>